Venous thromboembolism after stroke: a personal view based on my interpretation of the evidence.
Dennis
M
M
Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, UK.
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D048228:Intermittent Pneumatic Compression Devices; D011655:Pulmonary Embolism / Q000150:complications / Q000175:diagnosis; D012306:Risk; D020521:Stroke / Q000150:complications* / Q000175:diagnosis; D054556:Venous Thromboembolism / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology; D020246:Venous Thrombosis / Q000150:complications / Q000175:diagnosis
D000933:Antifibrinolytic Agents; D006493:Heparin